PMID- 33786126 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220421 IS - 1895-4588 (Print) IS - 2299-0054 (Electronic) IS - 1895-4588 (Linking) VI - 16 IP - 1 DP - 2021 Mar TI - Short versus long biliopancreatic limb in Roux-en-Y gastric bypass surgery for treatment of type 2 diabetes mellitus. PG - 129-138 LID - 10.5114/wiitm.2020.99997 [doi] AB - INTRODUCTION: Although laparoscopic Roux-en-Y gastric bypass (RYGB) is still widely accepted as a valid procedure in the treatment of obesity and type 2 diabetes mellitus (T2DM), there continues to be a significant controversy about how long the Roux and biliopancreatic limb should be bypassed for optimum results. AIM: To assess the effect of a longer biliopancreatic limb (BPL) length on glycemic control after RYGB in T2DM patients. MATERIAL AND METHODS: Eighty-four patients with uncontrolled T2DM who underwent RYGB between May 2010 and April 2017 were collected from the prospectively designed database. Forty patients (S-BPL group) received BPL lengths